Purchases and Sales Made in Q1 2024 in Avadel Pharmaceuticals PLC (AVDL)
This table provides information about the institutional ownership of Avadel Pharmaceuticals PLC (AVDL) during Q1 2024. The information is specifically focused on institutions that hold shares of AVADEL PHARMACEUTICALS PLC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2024
Q1 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-114K- 58.23% |
$1.44M - $1.97M
|
82.1K
$881K
|
|
Apr 22, 2024
Q1 2024
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-124K- 3.04% |
$1.56M - $2.14M
|
3.97M
$42.6M
|
|
Apr 22, 2024
Q1 2024
|
Wealth Effects LLC
|
SELL
|
- |
-152K- 6.29% |
$1.91M - $2.62M
|
2.26M
$24.3M
|
|
May 13, 2024
Q1 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-219K- 35.05% |
$2.75M - $3.77M
|
406K
$4.36M
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-327K- 32.92% |
$4.1M - $5.62M
|
665K
$7.14M
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-327K- 32.92% |
$4.1M - $5.62M
|
665K
$7.14M
|
|
May 15, 2024
Q1 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-352K- 19.0% |
$4.42M - $6.06M
|
1.5M
$16.1M
|
|
May 13, 2024
Q1 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-472K- 60.37% |
$5.92M - $8.12M
|
310K
$3.32M
|